Trivascular Technologies (TRIV) Inventory Turnover Ratio, from third quarter 2015 to third quarter 2014, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Trivascular Technologies, Inc.  (TRIV)
 

Trivascular Technologies Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2015, Trivascular Technologies's inventory turnover ratio sequentially decreased to 1.53 in the third quarter 2015, unsurprisingly, as the Trivascular Technologies markets continue to deteriorate, and TRIV's faces growing challenges to bring down its inventories. Trivascular Technologies's average inventory processing period in the Sep 30 2015 quarter, has increased to 239 days, from 228 days, in the Jun 30 2015 quarter.

Within Healthcare sector 247 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2015, to 1656, from total ranking in the second quarter 2015 at 1916.

TRIV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Trivascular Technologies, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIV Inventory Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Inventory Growth 22.04 % 20.5 % 27.73 % 21.7 % -
Y / Y Cost of Sales Growth 2.4 % 8.52 % -8.32 % - -6.07 %
Inventory Turnover Ratio (TTM) 1.53 1.6 1.64 1.78 1.42
TRIV's Total Ranking # 1656 # 1916 # 1938 # 1649 # 1938
Average inventory processing period 238 228 223 205 256
Seq. Inventory Growth 4.32 % 1.13 % 5.45 % 9.7 % 3.01 %
Seq. Cost of Sales Growth -8.12 % 11.85 % 1.2 % -1.54 % -2.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 112
Healthcare Sector # 248
Overall Market # 1656

Inventory Turnover Ratio Statistics
High Average Low
1.78 1.58 1.35
(Dec 31 2014)   (Sep 30 2014)



TRIV Company Profile >> Back to TRIV Efficiency Comparisons >> Compare TRIV Inventory Turnover Ratio to its Competitors

Financial Statements
Trivascular Technologies's Inventories $ 10 Millions Visit TRIV's Balance sheet
Trivascular Technologies's Cost of Revenues TTM $ 14 Millions Visit TRIV's Income Statement
What are TRIV's Sales? Visit TRIV's Sales by Segment

Other Inventory Turnover Ratios
Trivascular Technologies's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TRIV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TRIV's Competitors
Inventory Turnover Ratio for TRIV's Suppliers
Inventory Turnover Ratio for TRIV's Customers

You may also want to know
TRIV's Sales Growth Rates TRIV's Pe Price to earnings ratio TRIV's Receivables Turnover Ratio TRIV's Stock Quote
TRIV's Net Income Growth Rates TRIV's Ps Price to Sales ratio TRIV's Sales per Employee TRIV's Asset Turnover Ratio
TRIV's Net Margin TRIV's Pb Price to Book ratio TRIV's Financial Strength Ratios TRIV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2015 Inventories at quarter ending Sep 30 2015
Mimedx Group Inc   3.98 $ 18.816  Millions$ 5  Millions
Idexx Laboratories Inc  3.94 $ 699.426  Millions$ 178  Millions
Teva Pharmaceutical Industries Limited  3.93 $ 8,541.000  Millions$ 2,174  Millions
Therapeuticsmd Inc   3.90 $ 4.150  Millions$ 1  Millions
Opko Health Inc   3.88 $ 93.357  Millions$ 24  Millions
Cellular Biomedicine Group Inc   3.86 $ 1.421  Millions$ 0  Millions
Iradimed Corporation  3.85 $ 8.606  Millions$ 2  Millions
Vanda Pharmaceuticals Inc   3.76 $ 17.973  Millions$ 5  Millions
Intersect Ent Inc   3.75 $ 11.540  Millions$ 3  Millions
Exact Sciences Corporation  3.72 $ 20.235  Millions$ 5  Millions
Livewire Ergogenics Inc.  3.69 $ 0.145  Millions$ 0  Millions
Retractable Technologies Inc  3.66 $ 20.602  Millions$ 6  Millions
Heska Corporation  3.63 $ 57.141  Millions$ 16  Millions
China Biologic Products Holdings Inc   3.59 $ 100.495  Millions$ 28  Millions
Koru Medical Systems Inc   3.59 $ 4.937  Millions$ 1  Millions
Phibro Animal Health Corporation  3.55 $ 512.050  Millions$ 144  Millions
Dynatronics Corporation  3.53 $ 20.286  Millions$ 6  Millions
Ocular Therapeutix Inc   3.48 $ 0.507  Millions$ 0  Millions
Pacific Biosciences Of California Inc   3.47 $ 41.983  Millions$ 12  Millions
Utah Medical Products Inc  3.46 $ 16.140  Millions$ 5  Millions
Tearlab Corp  3.44 $ 11.995  Millions$ 3  Millions
Bard C R Inc  3.43 $ 1,300.700  Millions$ 380  Millions
Becton Dickinson And Company  3.39 $ 6,593.000  Millions$ 1,942  Millions
Alerislife Inc   3.37 $ 1,238.516  Millions$ 367  Millions
Abbott Laboratories  3.34 $ 8,878.000  Millions$ 2,659  Millions
Neurometrix Inc   3.34 $ 3.011  Millions$ 1  Millions
Antares Pharma Inc   3.31 $ 18.905  Millions$ 6  Millions
Halozyme Therapeutics Inc   3.30 $ 26.965  Millions$ 8  Millions
Bausch Health Companies Inc   3.29 $ 2,402.200  Millions$ 730  Millions
Alkermes Plc   3.27 $ 143.982  Millions$ 44  Millions

Date modified: 2026-08-29T17:19:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.